0001209191-17-065094.txt : 20171211
0001209191-17-065094.hdr.sgml : 20171211
20171211183019
ACCESSION NUMBER: 0001209191-17-065094
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171211
FILED AS OF DATE: 20171211
DATE AS OF CHANGE: 20171211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEIDEN JEFFREY M
CENTRAL INDEX KEY: 0001242825
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 171250604
MAIL ADDRESS:
STREET 1: 40 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-12-11
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001242825
LEIDEN JEFFREY M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
1
0
0
CEO & President
Common Stock
2017-12-11
4
S
0
20090
140.31
D
237407
D
Common Stock
2017-12-11
4
S
0
87578
141.35
D
149829
D
Common Stock
2017-12-11
4
S
0
12134
142.21
D
137695
D
Common Stock
2017-12-11
4
S
0
5198
143.39
D
132497
D
Common Stock
440
I
401(k)
Transaction made pursuant to Dr. Leiden's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $140.31 (range $139.85 to 140.84).
Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $141.35 (range $140.86 to $141.85).
Open market sales reported on this line occurred at a weighted average price of $142.21 (range $141.86 to $142.79).
Open market sales reported on this line occurred at a weighted average price of $143.39 (range $142.90 to $143.85).
/s/ Michael LaCascia, Attorney-in-Fact
2017-12-11